GEP201706683B - Usage of pidotimod to treat inflammatory bowel diseases - Google Patents

Usage of pidotimod to treat inflammatory bowel diseases

Info

Publication number
GEP201706683B
GEP201706683B GEAP201313982A GEAP2013013982A GEP201706683B GE P201706683 B GEP201706683 B GE P201706683B GE AP201313982 A GEAP201313982 A GE AP201313982A GE AP2013013982 A GEAP2013013982 A GE AP2013013982A GE P201706683 B GEP201706683 B GE P201706683B
Authority
GE
Georgia
Prior art keywords
pidotimod
inflammatory bowel
usage
bowel diseases
treat inflammatory
Prior art date
Application number
GEAP201313982A
Inventor
Federico Mailland
Francesco Scarci
Maurizio Caserini
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Priority to GEAP201313982A priority Critical patent/GEP201706683B/en
Publication of GEP201706683B publication Critical patent/GEP201706683B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pidotimod is applied to treat inflammatory bowel diseases.
GEAP201313982A 2013-04-05 2013-04-05 Usage of pidotimod to treat inflammatory bowel diseases GEP201706683B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAP201313982A GEP201706683B (en) 2013-04-05 2013-04-05 Usage of pidotimod to treat inflammatory bowel diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP201313982A GEP201706683B (en) 2013-04-05 2013-04-05 Usage of pidotimod to treat inflammatory bowel diseases

Publications (1)

Publication Number Publication Date
GEP201706683B true GEP201706683B (en) 2017-06-12

Family

ID=59844214

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201313982A GEP201706683B (en) 2013-04-05 2013-04-05 Usage of pidotimod to treat inflammatory bowel diseases

Country Status (1)

Country Link
GE (1) GEP201706683B (en)

Similar Documents

Publication Publication Date Title
HK1213818A1 (en) Therapeutic uses of empagliflozin
HK1215398A1 (en) Therapeutic uses of empagliflozin
EP3041578A4 (en) Treatment of inflammatory diseases by carbon materials
RS65037B1 (en) Treatment of cardiovascular diseases
EP2968244A4 (en) Compositions and methods for utilization of algal compounds
EP2958964A4 (en) Treatment of frequently touched surfaces to improve hygiene
IL244453A0 (en) Methods of determining response to therapy
MX2016006975A (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases.
ZA201409181B (en) Treatment of waste water
ZA202207530B (en) Use of phenoxypropylamine compounds to treat depression
JOP20140215B1 (en) Connector to facilitate lifting of wear parts
EP2964227A4 (en) Treatment and prophylaxis of kidney diseases
HK1220127A1 (en) Treatment of autoimmune diseases
HK1210937A1 (en) Use of pidotimod to treat psoriasis
EP3046629A4 (en) Treatment of inflammatory skin disease
PL3079684T3 (en) Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
EP3089984A4 (en) Novel compounds for the treatment of cancer and inflammatory diseases
GEP201706683B (en) Usage of pidotimod to treat inflammatory bowel diseases
GEP201706684B (en) Usage of pidotimod to treat irritable bowel syndrome
HK1216150A1 (en) Use of pidotimod to treat inflammatory bowel disease
HK1216151A1 (en) Use of pidotimod to treat irritable bowel syndrome
GEP20176633B (en) Use of pidotimod to treat psoriasis
GB201310488D0 (en) New therapeutic uses of enzyme inhibitors
IN2013MU02732A (en)
GB201306411D0 (en) Treatment of inflammatory conditions